atezolizumab,bevacizumab
roche
['atezo', 'hcc', 'bevacizumab', 'imbrave050']
imbrave050 study : adjuvant #atezolizumab plus #bevacizumab demonstrates improved recurrence-free survival for hepatocellular cancer (hcc) patients. overall survival needs to follow. #imbrave050 #hcc #cancerresearch #asco23 #livercancer 
What’s happening in the treatment world of Cancer and Medicine